We have no scientific information on the clinical and epidemiological characteristics and differences between men and women infected with HIV and receiving ART in Mexico. The aim of this study was to evaluate
Background Maternal, obstetric and neonatal factors that increase the possibility of mother-to-child HIV transmission (MTCT) are known as mechanisms of transmission. Our aim was to determine the risk factors associated with MTCT in Mexico. Methods We conducted a case–control study from March to December 2015. Cases were 60 mothers with HIV infection who transmitted HIV to their children, and controls were 120 mothers with HIV infection whose children tested negative for HIV. Data were extracted from medical records and a self-reported questionnaire for each participant. To determine associations with MTCT, odds ratios (ORs) and 95% confidence intervals (CI) were obtained with the chi-squared test and a logistic-regression modeling. Results A total of 180 patients were included. HIV diagnosis for cases occurred after pregnancy in 88% of the patients, during pregnancy in 9%, and before pregnancy in 3% of patients. Among the controls, 38% of patients were diagnosed before pregnancy, 32% during pregnancy, and 30% after pregnancy. In multivariate analysis, the risk factors associated with MTCT were: absence of antiretroviral treatment during pregnancy (OR 5.21; 95% CI 1.24–16.11; p = 0.019); vaginal delivery (OR 3.2; 95% CI 1.27–8.26; p = 0.014); forceps-assisted delivery (OR 13.4; 95% CI 1.91–93.66; p = 0.009); breastfeeding (OR 6.23; 95% CI 2.27–17.05; p = <0.001) and the practice of mixed breastfeeding (OR 4.6; 95% CI 1.56–13.73; p = 0.006). Conclusions MTCT is preventable with early diagnosis; treatment initiation before pregnancy and avoidance breastfeeding could decrease the risk of transmitting HIV to their children.
Background: Human immunodeficiency virus (HIV) infection has become a disease in epidemiological transition since the introduction of antiretroviral therapy (ART); however, its control depends on adherence to therapy. There are some studies in Mexico regarding such adherence but they have had heterogeneous results. We aimed to determine the prevalence of ART adherence and risk factors associated with non-adherence among HIV-infected adults in a tertiary care hospital in Mexico. Methods: This was a cross-sectional study conducted at the Hospital de Infectología, "La Raza" National Medical Center, Mexico City. The subjects of the study were HIV-infected adults after at least 6 months on ART. They answered a questionnaire involving socio-demographics, biochemical, and clinical variables. Adherence was measured using the simplified medication adherence questionnaire Results: Three hundred seventy-six HIV-infected patients were included in the study. The median age was 35 years (interquartile range, IQR, 29-44) and most of them were men (79.3%). Among the participants, 73% (95% confidence interval, CI, 68.2-77.4%) adhered to the medications prescribed. Factors associated with good adherence were being male (odds ratio, OR, 0.43; 95% CI, 0.22-0.83) and the absence of alcohol use (OR, 0.27; 95% CI, 0.12-0.58); factors associated with non-adherence were a history of ≥2 ART regimens (OR, 1.95; 95% CI, 1.05-3.62), time spend attending medical care or receiving drugs (OR, 2.40; 95% CI, 1.22-4.70), and persistent viremia (OR, 2.72; 95% CI, 1.42-5.19; P<0.005). Conclusion: In the era of ART as prevention for transmission of HIV as well as treatment for HIV-positive individuals irrespective of CD4 cell counts, the importance of adherence has grown. Treatment failure reduces future treatment options and therefore long-term clinical success as well as increases the possibility of developing drug resistant mutations. Being male and a lack of alcohol use were factors associated with higher rates of adherence, whereas previous use of ART, more ARV regimens, and a longer time waiting for medical care or drugs, were associated with nonadherence in this HIV-infected population. Incomplete ART adherence is associated with persistent viremia. J o urnal o f A ID S & Cli n ic a l R es earc h
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.